ing Results, 2007-2011 (US$ million).98
Fig.11: Percentage of Alere's Revenue by Segment, 2011..98
Fig.12: Percentage of Alere's Revenue by Region, 2011..99
Alere Professional Diagnostics Operating Results, 2007-2011 (US$ million)..99
Alere Professional Diagnostics Net Sales & Services Revenue, 2007-2011 (US$ million)..99
Fig.13: Alere Professional Diagnostics Net Sales & Services Revenue by Product, 2011..100
Alere Consumer Diagnostics Operating Results, 2007-2011 (US$ million).100
Latest Results .100
Axis Shield - Financial Performance101
Fig.14: Axis-Shield Revenue by Business Unit, 2010..102
Fig.15: Axis-Shield Revenue by Region, 2010.102
Axis-Shield - POC Segment Operating Results, 2006-2010 (£ million) 102
Axis-Shield - POC Sales by Product Line, 2006-2010 (£ million)..103
Fig.16: Axis-Shield POC Sales by Product, 2010103
Fig.17: Axis-Shield Afinion Sales by Region, 2010103
bioMérieux.104
bioNexia POC Tests 104
VIDAS Tests.. 104
VIDAS NT-proBNP .104
VIDAS Troponin I Ultra.104
VIDAS D-Dimer Exclusion..105
VIDAS B-R-A-H-M-S PCT. Test.105
Current Alliances. 105
Uppsala Clinical Research Center..105
Philips..105
Sysmex 106..106
ReLIA Diagnostic Systems.106
Roche Diagnostics.106
Brahms106
Financial Performance 106
bioMérieux - Operating Results, 2007-2011 (EUR million).106
Fig.18: Percentage of bioMerieux' Revenue by Product Type, 2011107
Fig.19: Percentage of bioMerieux' Revenue by Region, 2011107
International Technidyne Corporation 108
Products. 108
ProTime Microcoagulation System.108
Hemochron Whole Blood Coagulation System108
IRMA TRUpoint Blood Analysis System.109
AVOXimeter Whole Blood CO Oximeter and Oximeter.109
Current Alliances..110
Alere.110
Financial Performance .110
International Technidyne Operating Results, 2004-2009 (US$ million).110
Fig.20: Inter
'/>"/>SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 Related medicine technology :1.
Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology2.
Leading Cardiology Experts Advice on Dietary Supplement Niacins: Make Informed Choices at the Shelf and Scan the Label for Nicotinic Acid3.
Philips and Corindus announce distribution agreement to sell Corindus robotic-assisted interventional cardiology system in the United States4.
Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others5.
North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others6.
50% of U.S. News & World Reports "Best Hospitals" for Cardiology & Heart Surgery Making the SynCardia Total Artificial Heart Part of Their Toolbox7.
Aequus BioPharma Appoints Ronald J. Berenson, M.D. President and CEO8.
Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint9.
AAIPharma Appoints Senior Director of Biopharmaceutical Development10.
uniQure Appoints Hans Christian Rohde Chief Commercial Officer11.
CIVCO Medical Solutions Appoints Senior Vice President and General Managers to Business Units